Compare SCLX & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | SELF |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.9M | 57.3M |
| IPO Year | N/A | 1997 |
| Metric | SCLX | SELF |
|---|---|---|
| Price | $7.32 | $5.07 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 28.1K | 23.6K |
| Earning Date | 04-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 5.71% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $12,530,280.00 |
| Revenue This Year | N/A | $1.59 |
| Revenue Next Year | $749.70 | $1.62 |
| P/E Ratio | ★ N/A | $33.77 |
| Revenue Growth | N/A | ★ 2.79 |
| 52 Week Low | $0.18 | $4.73 |
| 52 Week High | $34.27 | $5.83 |
| Indicator | SCLX | SELF |
|---|---|---|
| Relative Strength Index (RSI) | 37.25 | 47.85 |
| Support Level | $4.56 | $5.03 |
| Resistance Level | $7.50 | $5.09 |
| Average True Range (ATR) | 0.72 | 0.08 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 4.62 | 8.91 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.